LUMICKS
@lumicks.bsky.social
550 followers 2.1K following 120 posts
Empowering scientists with tools that reveal crucial insights not available before, at the molecular and cellular level | Dynamic single-molecule & Cell Avidity
Posts Media Videos Starter Packs
Pinned
lumicks.bsky.social
Hey Bluesky! 🌤️ We just flew in from elsewhere and are eager to explore the region here! 🐦 Please re-share this post so we can follow you and help grow the single-molecule and cell avidity communities on here! 🔬⚗️
lumicks.bsky.social
Targeting FACT in cancer cells has shown efficacy in preclinical trials, but by which mechanism? Unclear.

Enter: this new study from the Bustamante Lab at UC Berkeley. It reveals that NDF-FACT condensates form on transcribing PolII and enhance nucleosome disassembly and PolII progression.
Reposted by LUMICKS
danielabarilla.bsky.social
It has been a blast 💥!Awesome atmosphere, networking & knowledge exchange at @biophychrom.bsky.social
Huge thanks 🙏 to all the Participants, Rachel & Kinga from @biochemsoc.bsky.social & the Sponsors @plasmidsaurus.bsky.social @lumicks.bsky.social @emanuellissek.bsky.social @ei-science.bsky.social
Speaker delivering a talk at the meeting. Scientists at the old Eagle 🦅& Child pub Gala dinner at the 14th century timber-framed Hospitium in York. Group photo with St Mary’s Abbey ruins in the background
lumicks.bsky.social
Finding the right CAR affinity is tricky: too low fails, too high impairs function. Measuring cell avidity helps define the productive window, where affinity + avidity drive CAR clustering, persistence & efficacy.

👉 Join Dr. Markus Barden: bit.ly/464vLyZ
lumicks.bsky.social
TODAY: Discover how Prof. Taekjip Ha (Harvard University) used the LUMICKS C-Trap to uncover real-time dynamics of chromatin remodelers and transcription factors at the single-molecule level.

Join the webinar: bit.ly/3VdxuNs
lumicks.bsky.social
CAR T cell therapy has revolutionized treatment for blood cancers, but why does it still not work on solid tumors?

Register for this upcoming webinar by Markus Barden (postdoc from Hinrich Abken's lab, Leibniz Institute for Immunotherapy) to learn more: bit.ly/464vLyZ
lumicks.bsky.social
Looking back at a fantastic SMBio 2025 China at Hefei this past week 💪! Thank you USTC and Guoqiang Bi & Sai Li for hosting and co-organizing this memorable event for the single-molecule community.
Group photo of the attendees of the SMBio 2025 China symposium in Hefei.
lumicks.bsky.social
👌 How to visualize dynamic protein-DNA interactions in real time, including co-localization and diffusion, to uncover critical molecular mechanisms.

Created in collaboration with Prof. Bennett van Houten @benvh123.bsky.social
lumicks.bsky.social
✌ How to leverage standard mammalian cell culture techniques to perform sophisticated single-molecule experiments, eliminating the need for extensive biochemistry expertise.
lumicks.bsky.social
What you'll learn:

👉 How to observe DNA-binding proteins in their natural state, complete with post-translational modifications, revealing insights inaccessible through purified protein assays.
lumicks.bsky.social
This guide can empower you to bridge the gap between cellular biology and single-molecule biophysics 👇.

Read: "Accelerating DNA-Protein Interaction Experiments with Nuclear Extracts in the C-Trap". Created in collaboration with Prof. Bennett Van Houten (University of Pittsburgh).

bit.ly/4fPnHXk
Accelerating DNA-protein interaction experiments with nuclear extracts in the C-Trap - Application Note - LUMICKS
Category: DNA-Binding proteins | Access our application note titled 'Accelerating DNA-protein interaction experiments with nuclear extracts in the C-Trap' .
www.lumicks.com
lumicks.bsky.social
Congrats on your new C-Trap system! We’re excited to support your journey in single-molecule research and are fully committed to helping you make scientific breakthroughs!
umeaplantsciencecentre.se
🧪🧬NEWS - Research facility allows to monitor molecules in motion

At the new C-Trap Facility, scientist can now manipulate and observe dynamic molecular processes in real time.🔬

Curious to learn more? Take a look here👇:
www.upsc.se/about-upsc/n...

📸 Mattias Pettersson @umeauniversitet.bsky.social
A short-haired men in a white labcoat is pipetting something into a large, black machine. Photo credit: Mattias Pettersson, Umeå University Three computer screens are displayed and before is a hand controlling a joystick. Photo credit: Mattias Pettersson, Umeå University A hand is holding a black device that is connected to small transparent pipes. Photo credit: Mattias Pettersson, Umeå University A women and a men in white labcoats are sitting in front of a computer screen and discuss. The women is shown on something on the screen. Photo credit: Mattias Pettersson, Umeå University
lumicks.bsky.social
About 2 months ago, our product managers Bas Groen and Adalberto Costessi introduced the latest upgrades for the C-Trap.

Catch the intro from LUMICKS product managers on how to make your C-Trap faster, easier, and more reproducible. Watch now: www.lumicks.com/webinars/c-t...
Watch: C-Trap Accelerator Suite - LUMICKS
Speaker: LUMICKS, . In this webinar, we discuss C-Trap Accelerator Suite. Category:
www.lumicks.com
lumicks.bsky.social
Discuss single-molecule science with world-renowned Prof.
𝗧𝗮𝗲𝗸𝗷𝗶𝗽 𝗛𝗮 (Harvard)! Join the upcoming 𝗡𝗮𝘁𝘂𝗿𝗲 𝘄𝗲𝗯𝗶𝗻𝗮𝗿 to learn how dynamic single-molecule tools reveal new mechanisms behind nucleosome mobilization and transcriptional control!

Registrations are now open:
Nature Portfolio webcasts
If you’ve already registered, please log in to the webcast.
web.lumicks.com
lumicks.bsky.social
Avidion is our next-generation Cell Avidity platform. It is ideal for high-throughput screening and characterization of cell therapy candidates. Avidion empowers discoveries across a broad range of immunotherapy research.
lumicks.bsky.social
Cell Avidity measures the combined strength of cell-cell and cell-protein interactions. It provides direct, physiologically relevant insights into binding in its full, dynamic complexity. Cell Avidity bridges the gap between traditional in vitro assays and real-life in vivo functionality.
lumicks.bsky.social
At LUMICKS, we share the mission to accelerate the development of breakthrough immunotherapies. That’s why we’re excited to support the PICI community by providing early access to our 𝗔𝘃𝗶𝗱𝗶𝗼𝗻, our new Cell Avidity platform.
lumicks.bsky.social
𝗪𝗲’𝗿𝗲 𝗽𝗿𝗼𝘂𝗱 𝘁𝗼 𝘀𝘂𝗽𝗽𝗼𝗿𝘁 𝘁𝗵𝗲 𝗣𝗮𝗿𝗸𝗲𝗿 𝗜𝗻𝘀𝘁𝗶𝘁𝘂𝘁𝗲 𝗳𝗼𝗿 𝗖𝗮𝗻𝗰𝗲𝗿 𝗜𝗺𝗺𝘂𝗻𝗼𝘁𝗵𝗲𝗿𝗮𝗽𝘆 (𝗣𝗜𝗖𝗜) 𝗡𝗲𝘁𝘄𝗼𝗿𝗸 𝗶𝗻 𝘁𝗵𝗲 𝗳𝗶𝗴𝗵𝘁 𝗮𝗴𝗮𝗶𝗻𝘀𝘁 𝗰𝗮𝗻𝗰𝗲𝗿. @parkerici.bsky.social
lumicks.bsky.social
Exciting to see the C-Trap in the hands of talented researchers like Spencer! 🎉
lumicks.bsky.social
🛎️ SMBio Nordics abstract deadline postponed to August 8

Allowing for some (well-deserved) offline time of the single-molecule community during the Nordic summer, the organisation of SMBio 2025 Nordics decided to delay the abstract deadline with ~2 weeks until August 8. Submit here: bit.ly/4l3Sxgx
SMBio 2025 Nordics - Symposium - LUMICKS
We are excited to share that we are organizing the SMBio 2025 Nordics, aimed at bringing together our current and future Nordic C-trap users for two days of engaging discussions and networking. Follow...
bit.ly
lumicks.bsky.social
Speed up C-Trap user training, assay troubleshooting or performance verification 👉 try the new C-Trap Reference Kit.

The kit provides standardized and validated reagents for a complete DNA-protein binding assay, incl. data analysis with reference values.

Find the protocol & more: bit.ly/4mcXuUM
Colorful mockup of the C-Trap reference kit for optical tweezers experiments by LUMICKS
lumicks.bsky.social
The new DNA Repeat Assembly kit can deliver C-Trap users with the next increase in throughput, leading to statistically relevant results in a fraction of the time required.

👉 Find the DNA Repeat Assembly kit and the application note, including proof-of-concept data, in our store: bit.ly/3GSMBZ8
Mockup of the DNA Repeat assembly kit